Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hepatitis

  Free Subscription


Articles published in Transplantation

Retrieve available abstracts of 26 articles:
HTML format



Single Articles


    May 2022
  1. SIBULESKY L, Leca N, Limaye AP, Ramasamy B, et al
    Survival Benefit in Older Patients Transplanted With Viremic Hepatitis C Positive Kidneys When Compared With High KDPI Kidneys.
    Transplantation. 2022 May 27. pii: 00007890-990000000-00059.
    PubMed     Abstract available


    April 2022
  2. MARTINI S, Tandoi F, Romagnoli R, Rizzetto M, et al
    Liver Transplantation in Hepatitis B/Hepatitis D (Delta) Virus Coinfected Recipients.
    Transplantation. 2022 Apr 11. pii: 00007890-990000000-00024.
    PubMed     Abstract available


  3. BEKKI Y, Crismale JF, Myers B, Schiano TD, et al
    Varying Utilization Rates but Superior Outcomes in Liver Transplantation From Hepatitis C-positive Donors in the US: An Analysis of the OPTN/UNOS Database.
    Transplantation. 2022 Apr 6. pii: 00007890-990000000-00025.
    PubMed     Abstract available


  4. GUPTA G, Devarakonda T, Sharma A, Miles M, et al
    Ultrashort Duration Prophylaxis for Hepatitis C Donor Positive to Recipient Negative Simultaneous Kidney/Pancreas Transplants.
    Transplantation. 2022;106:e234-e235.
    PubMed    


    March 2022
  5. BITTERMANN T, Mahmud N, Weinberg EM, Reddy KR, et al
    Rising Trend in Waitlisting for Alcoholic Hepatitis With More Favorable Outcomes Than Other High Model for End-stage Liver Disease in the Current Era.
    Transplantation. 2022 Mar 24. pii: 00007890-900000000-95041.
    PubMed     Abstract available


  6. TROTTER J
    Commentary on Rising Trend in Waitlisting for Alcoholic Hepatitis With More Favorable Outcomes Than Other High Model for End-stage Liver Disease in the Current Era.
    Transplantation. 2022 Mar 24. pii: 00007890-900000000-95040.
    PubMed    


    February 2022
  7. COTTER TG, Charlton M
    The Authors' Reply: Geographic Variation in the Utilization of HCV-viremic Donors Into HCV-negative Recipients.
    Transplantation. 2022;106:e166.
    PubMed    


  8. BEKKI Y, Myers B
    Geographic Variation in the Utilization of HCV-viremic Donors into HCV-negative Recipients.
    Transplantation. 2022;106:e165.
    PubMed    


  9. LIN SH, Lin MT, Wang CC, Chen CL, et al
    Vaccination for HAV: A Lesson From Acute Hepatitis A Superinfection on Chronic B Hepatitis With Lifesaving Living Donor Liver Transplantation for Hepatic Failure.
    Transplantation. 2022;106:e163-e164.
    PubMed    


  10. WALLER KMJ, De La Mata NL, Rosales BM, Hedley JA, et al
    Characteristics and Donation Outcomes of Potential Organ Donors Perceived to Be at Increased Risk for Blood-borne Virus Transmission: An Australian Cohort Study 2010-2018.
    Transplantation. 2022;106:348-357.
    PubMed     Abstract available


    July 2021
  11. RICHTER BI, Parent B, Lonze BE
    The Moral Necessity to Increase Access to HCV+ Transplants With Early Treatment for HCV Naive Patients.
    Transplantation. 2021 Jul 22. pii: 00007890-900000000-95189.
    PubMed    


    May 2021
  12. MUTHUKUMAR T, Akat KM, Yang H, Schwartz JE, et al
    Serum MicroRNA Transcriptomics and Acute Rejection or Recurrent Hepatitis C Virus in Human Liver Allograft Recipients: A Pilot Study.
    Transplantation. 2021 May 11. pii: 00007890-900000000-95253.
    PubMed     Abstract available


    February 2021
  13. CALABRESE DR
    Ribavirin to the Rescue: Natural Killer Cell Function After Hepatitis C Virus Treatment in Liver Transplant Recipients.
    Transplantation. 2021 Feb 12. pii: 00007890-900000000-95359.
    PubMed    


  14. YOELI D, Choudhury RA, Moore HB, Sauaia A, et al
    Are Hepatitis C Positive Female Liver Transplant Recipients Still at Increased Risk for Graft Failure? Re-Examining the Disparity in the Modern Era of Direct Acting Antiviral Agents.
    Transplantation. 2021 Feb 11. pii: 00007890-900000000-95364.
    PubMed     Abstract available


  15. HUCKABY LV, Seese LM, Handzel R, Wang Y, et al
    Center-level Utilization of Hepatitis C Virus Positive Donors for Orthotopic Heart Transplantation.
    Transplantation. 2021 Feb 8. doi: 10.1097/TP.0000000000003674.
    PubMed     Abstract available


    January 2021
  16. FUJISAKI T, Mikami T, Kuno T, Moss N, et al
    Effect of Hepatitis C Virus Infection on Heart Transplants in the Current Era.
    Transplantation. 2021 Jan 25. pii: 00007890-900000000-95404.
    PubMed     Abstract available


    December 2020
  17. ADENUGBA A, Hornung M, Weigand K, Peschel G, et al
    Ribavirin Improves NK Cell IFNgamma Response During Sofosbuvir-based DAA Therapy in CV-infected Liver Transplant Recipients.
    Transplantation. 2020 Dec 29. pii: 00007890-900000000-95432.
    PubMed     Abstract available


    November 2020
  18. BIAN X, Fan X, Wang Y
    Influence of Asymptomatic Carriers With COVID-19 on Transplantation Resumption in Wuhan.
    Transplantation. 2020;104:e328.
    PubMed    


    October 2020
  19. NGUYEN T, Sise ME, Delgado C, Williams W, et al
    Race, Education, and Gender Disparities in Transplantation of Kidneys from Hepatitis C Viremic Donors.
    Transplantation. 2020 Oct 29. doi: 10.1097/TP.0000000000003511.
    PubMed     Abstract available


    August 2020
  20. FALLAHZADEH MA, Trotter JF
    An Experiment of Nature: HBV-naive Recipients Receiving Liver Grafts With HBV Core Antibody-positive Donors Without Antiviral Prophylaxis.
    Transplantation. 2020;104:e245-e246.
    PubMed    


    June 2020
  21. COTTER TG, Aronsohn A, Reddy KG, Charlton M, et al
    Liver Transplantation of HCV-Viremic Donors into HCV-Negative Recipients in the USA: Increasing Frequency with Profound Geographic Variation.
    Transplantation. 2020 Jun 29. doi: 10.1097/TP.0000000000003382.
    PubMed     Abstract available


  22. BAE S, Durand CM, Garonzik-Wang JM, Chow EKH, et al
    Antithymocyte Globulin Versus Interleukin-2 Receptor Antagonist in Kidney Transplant Recipients With Hepatitis C Virus.
    Transplantation. 2020;104:1294-1303.
    PubMed     Abstract available


    January 2020
  23. GORGEN A, Galvin Z, Huang AC, Vinaixa C, et al
    The Impact of Direct Acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients with Hepatocellular Carcinoma Listed for Liver Transplantation.: An International Multicenter Study.
    Transplantation. 2020 Jan 16. doi: 10.1097/TP.0000000000003115.
    PubMed     Abstract available


    June 2019
  24. GARDINER A, Liu K, Bonnichsen M, Joshi V, et al
    Immunity to vaccine-preventable viral infections in Australians being evaluated for liver transplantation.
    Transplantation. 2019 Jun 28. doi: 10.1097/TP.0000000000002722.
    PubMed     Abstract available


    February 2019
  25. EKSER B, Chen AM, Kubal CA, Fridell JA, et al
    DELAYED KIDNEY TRANSPLANTATION AFTER 83 HOURS OF COLD ISCHEMIA TIME IN COMBINED LIVER-KIDNEY TRANSPLANT.
    Transplantation. 2019 Feb 14. doi: 10.1097/TP.0000000000002673.
    PubMed    


    September 2018
  26. CROOME KP, Mathur AK, Pungpapong S, Lee DD, et al
    Equivalent Outcomes with Retransplantation and Primary Liver Transplantation in the Direct Acting Antiviral Era.
    Transplantation. 2018 Sep 21. doi: 10.1097/TP.0000000000002460.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: